Stable composition comprising polydatin
By adding caffeinylquinic acid compound and vitamin B3 compound to the kaleinol composition and presenting water and solubilizer in specific proportions and forms, the stability of the composition under light and thermal conditions is solved, and it is significantly improved. Light and thermal stability ensures retention of syringoside.
Patent Information
- Application Number
- CN202180049556.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-10-06
- Filing Date
- 2021-08-13
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2041-08-13
AI Technical Summary
Compositions containing gusmine glycoside have challenges in light stability and are difficult to maintain stability, especially under ultraviolet and other radiation conditions.
Using a combination of kalein, caffeylquinic acid compound and vitamin B3 compound, an excellent thermal and light-stabilizing composition, including water and solubilizing agent, is formed to improve the stability of the composition by adjusting its proportions and formulations.
The stability of the composition under cooling and light conditions was achieved, and the retention rate of kalein oncoside reached 50% or higher after exposure to light, significantly improving its thermal and light stability.
Smart Images

Figure BDA0004048689600000021 
Figure BDA0004048689600000022 
Figure BDA0004048689600000023
Abstract
Description
Technical Field
[0001] The present invention relates to a composition, preferably a cosmetic or dermatological composition, comprising polydatin but which is in particular stable with respect to photostability. Background Art
[0002] The formation of free radicals is widely believed to play an important role in the mechanism of skin aging. Free radicals are highly reactive molecular species with unpaired electrons that can directly damage various cell membranes, lipids, proteins, RNA and DNA. The damaging effects of the free radicals, which are usually present in the form of reactive oxygen species, are induced inside tissues and cells during normal metabolism and are induced externally by various oxidative stresses. Ultraviolet radiation and environmental pollution can accelerate skin aging by producing free radicals in the skin. Antioxidants protect cells from oxidative stress damage by scavenging free radicals and inhibiting oxidation reactions. Topical application of antioxidants is widely used in skin care products to prevent skin aging. Previously, it has been shown in the cosmetic field that polyphenols synergize with other antioxidants such as vitamin E and carotenoids. Summary of the invention
[0003] Polydatin (also known as picea glycosides) is an antioxidant and can be used as a potent whitening active ingredient. However, compositions containing polydatin are difficult to stabilize, particularly with respect to photosynthesis.
[0004] It is an object of the present invention to provide a composition comprising polydatin but which is in particular stable with respect to photostability.
[0005] The above objects of the present invention can be achieved by using a composition comprising:
[0006] (a) Polydatin;
[0007] (b) at least one caffeoylquinic acid compound;
[0008] (c) at least one vitamin B3 compound; and
[0009] (d) water,
[0010] in
[0011] The amount of (b) the caffeoylquinic acid compound is 0.5 wt% or more, preferably 1.0 wt% or more, and more preferably 1.5 wt% or more, relative to the total weight of the composition.
[0012] (a) Polydatin can be obtained from plants.
[0013] The amount of (a) polydatin in the composition according to the present invention may range from 0.01 to 3 wt %, preferably from 0.05 to 2 wt %, and more preferably from 0.1 to 1 wt % relative to the total weight of the composition.
[0014] (b) The caffeoylquinic acid compound can be represented by the following formula (I):
[0015]
[0016] wherein R1, R2, R3 and R4 independently represent a hydrogen atom or a caffeoyl group represented by the following formula (II):
[0017]
[0018] Provided that at least one of R1, R2, R3 and R4 represents a caffeoyl group of formula (II).
[0019] (b) The caffeoylquinic acid compound may be chlorogenic acid.
[0020] (b) Caffeoylquinic acid compounds can be obtained from plants.
[0021] The amount of (b) caffeoylquinic acid compound in the composition according to the present invention may range from 0.5 to 15 wt %, preferably from 1.0 to 10 wt %, and more preferably from 1.5 to 5 wt % relative to the total weight of the composition.
[0022] (c) Vitamin B3 compounds can be represented by the following formula (III):
[0023]
[0024] wherein R represents -CONH2, -COOH, CH2OH, -CO-NH-CH2-COOH or -CO-NH-OH.
[0025] (c) The vitamin B3 compound may be niacinamide.
[0026] The amount of (c) vitamin B3 compound in the composition according to the invention may range from 0.1% to 15%, preferably from 0.5% to 10%, and more preferably from 1% to 5% by weight relative to the total weight of the composition.
[0027] The weight ratio of the amount of (a) polydatin / (b) caffeoylquinic acid compound may be 0.1 to 1, preferably 0.2 to 0.5, and more preferably 0.3 to 0.4.
[0028] The weight ratio of the amount of (a) polydatin / (c) vitamin B3 compound may be 0.01 to 0.5, preferably 0.05 to 0.3, and more preferably 0.1 to 0.2.
[0029] The weight ratio of the amount of (c) vitamin B3 compound / (b) caffeoylquinic acid compound may be 1 to 8, preferably 1.5 to 4, and more preferably 2 to 3.
[0030] The composition according to the present invention may be in the form of an O / W emulsion, preferably a nano O / W emulsion or a micro O / W emulsion, and more preferably a nano O / W gel emulsion or a micro O / W gel emulsion.
[0031] The invention also relates to a cosmetic method for treating keratinous materials such as the skin, comprising the step of applying to the keratinous materials a composition according to the invention.
[0032] Best Mode for Carrying Out the Invention
[0033] After diligent research, the inventors have found that it is possible to provide compositions comprising polydatin but which are particularly stable with respect to photostability.
[0034] Therefore, the composition according to the invention comprises:
[0035] (a) Polydatin;
[0036] (b) at least one caffeoylquinic acid compound;
[0037] (c) at least one vitamin B3 compound; and
[0038] (d) water,
[0039] in
[0040] The amount of (b) the caffeoylquinic acid compound is 0.5 wt% or more, preferably 1.0 wt% or more, and more preferably 1.5 wt% or more, relative to the total weight of the composition.
[0041] The composition according to the present invention is stable to several factors, including cooling and light, in particular light such as visible light, ultraviolet light and infrared light. Therefore, the composition according to the present invention can have excellent thermal stability and light stability, in particular light stability.
[0042] The term "excellent thermal stability" means herein that after cooling to, for example, 4°C, for a certain period of time (for example, 1 month), the composition according to the present invention is visually homogeneous and does not cause precipitation of polydatin, which may be in the form of crystalline particles.
[0043] The term "excellent photostability" herein means that 50% or more, preferably 55% or more, and more preferably 60% or more of polydatin before exposure to light can be retained after exposure to light.
[0044] Hereinafter, the composition according to the present invention will be explained in a more detailed manner.
[0045] [Polydatin]
[0046] The composition according to the present invention comprises (a) polydatin.
[0047] Polydatin is a stilbene compound that can be described as 3,4′,5-trihydroxystilbene-3-β-mono-D glucoside. Stilbene compounds have strong natural antioxidant properties of free radical quenching and oxidative stress limitation. These properties can be used in skin care or sunscreen products, including compositions according to the present invention. When exposed to sunlight or other radiation, polydatin with trans conformational activity will photoisomerize to cis polydatin with less biological activity.
[0048] The amount of (a) polydatin in the composition according to the present invention may be 0.01 wt % or more, preferably 0.05 wt % or more, and more preferably 0.1 wt % or more, relative to the total weight of the composition.
[0049] The amount of (a) polydatin in the composition according to the present invention may be 3 wt% or less, preferably 2 wt% or less, and more preferably 1 wt% or less, relative to the total weight of the composition, provided that the amount of (a) polydatin is not 0.
[0050] The amount of (a) polydatin in the composition according to the present invention may range from 0.01 to 3 wt %, preferably from 0.05 to 2 wt %, and more preferably from 0.1 to 1 wt % relative to the total weight of the composition.
[0051] [Caffeoylquinic acid compounds]
[0052] The composition according to the invention comprises (b) at least one caffeoylquinic acid compound. If two or more caffeoylquinic acid compounds are used, they may be the same or different.
[0053] (b) Caffeoylquinic acid compound Herein refers to a compound having a quinic acid structure containing at least one caffeoyl group or radical.
[0054] (b) The caffeoylquinic acid compound can be represented by the following formula (I):
[0055]
[0056] wherein R1, R2, R3 and R4 independently represent a hydrogen atom or a caffeoyl group represented by the following formula (II):
[0057]
[0058] Provided that at least one of R1, R2, R3 and R4 represents a caffeoyl group of formula (II).
[0059] As examples of (b) caffeoylquinic acid compounds, there may be mentioned 3-caffeoylquinic acid (chlorogenic acid), 4,5-dicaffeoylquinic acid, 3,5-dicaffeoylquinic acid, 1,3-dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 3,4,5-tricaffeoylquinic acid, and mixtures thereof.
[0060] Preferably, the (b) caffeoylquinic acid compound is chlorogenic acid.
[0061] The amount of (b) the caffeoylquinic acid compound in the composition according to the present invention is 0.5 wt% or more, preferably 1.0 wt% or more, and more preferably 1.5 wt% or more, relative to the total weight of the composition.
[0062] The amount of (b) caffeoylquinic acid compound in the composition according to the present invention may be 15 wt % or less, preferably 10 wt % or less, and more preferably 5 wt % or less, relative to the total weight of the composition, provided that the amount of (b) caffeoylquinic acid compound is not 0.
[0063] The amount of (b) caffeoylquinic acid compound in the composition according to the present invention may range from 0.5 to 15 wt %, preferably from 1.0 to 10 wt %, and more preferably from 1.5 to 5 wt % relative to the total weight of the composition.
[0064] [Vitamin B3 compounds]
[0065] The composition according to the invention comprises (c) at least one vitamin B3 compound. If two or more vitamin B3 compounds are used, they may be the same or different.
[0066] Vitamin B3 compounds herein refer to compounds in the vitamin B3 group and derivatives thereof.
[0067] Vitamin B3, also known as vitamin PP, is herein a compound represented by the following formula (III):
[0068]
[0069] Wherein R can be -CONH2 (nicotinamide), -COOH (nicotinic acid or nicotinic acid), or CH2OH (nicotinyl alcohol), -CO-NH-CH2-COOH (nicotinuric acid) or -CO-NH-OH (nicotinyl hydroxamic acid). Nicotinamide is preferred.
[0070] Vitamin B3 derivatives that may be mentioned include, for example, nicotinic acid esters, such as tocopheryl nicotinate, amides derived from nicotinamide by substitution of the hydrogen group of -CONH2, products from reactions with carboxylic acids and amino acids, esters of nicotinic alcohol and carboxylic acids, such as acetic acid, salicylic acid, glycolic acid or palmitic acid.
[0071] The following derivatives may also be mentioned: 2-chloronicotinamide, 6-methylnicotinamide, 6-aminonicotinamide, N-methylnicotinamide, N,N-dimethylnicotinamide, N,N-diethylnicotinamide, N-pyridylmethylnicotinamide, N-allylnicotinamide, N-(hydroxymethyl)nicotinamide, quinolinic acid imide, nicotinanilide, N-benzylnicotinamide, N-ethylnicotinamide, nifenazone, nicotinaldehyde, isonicotinic acid, methylisonicotinic acid, thionicotinamide, niacinamide, 2-mercaptonicotinic acid, nicotinamide and nicotinamide, methyl nicotinate and sodium nicotinate.
[0072] Other vitamin B3 derivatives that may be mentioned include its inorganic salts, for example chlorides, bromides, iodides or carbonates; and its organic salts, for example salts obtained by reaction with carboxylic acids, such as acetates, salicylates, glycolates, lactates, malates, citrates, mandelates, tartrates, etc.
[0073] The amount of (c) vitamin B3 compound in the composition according to the present invention may be 0.1 wt% or more, preferably 0.5 wt% or more, and more preferably 1 wt% or more, relative to the total weight of the composition.
[0074] The amount of (c) vitamin B3 compound in the composition according to the present invention may be 15 wt % or less, preferably 10 wt % or less, and more preferably 5 wt % or less, relative to the total weight of the composition, provided that the amount of (c) vitamin B3 compound is not 0.
[0075] The amount of (c) vitamin B3 compound in the composition according to the invention may range from 0.1% to 15%, preferably from 0.5% to 10%, and more preferably from 1% to 5% by weight relative to the total weight of the composition.
[0076] (Weight ratio)
[0077] The weight ratio of the amount of (a) polydatin / (b) caffeoylquinic acid compound may be 0.1 or more, preferably 0.2 or more, and more preferably 0.3 or more.
[0078] The weight ratio of the amount of (a) polydatin / (b) caffeoylquinic acid compound may be 1 or less, preferably 0.5 or less, and more preferably 0.4 or less.
[0079] The weight ratio of the amount of (a) polydatin / (b) caffeoylquinic acid compound may be 0.1 to 1, preferably 0.2 to 0.5, and more preferably 0.3 to 0.4.
[0080] The weight ratio of the amount of (a) polydatin / (c) vitamin B3 compound may be 0.01 or more, preferably 0.05 or more, and more preferably 0.1 or more.
[0081] The weight ratio of the amount of (a) polydatin / (c) vitamin B3 compound may be 0.5 or less, preferably 0.3 or less, and more preferably 0.2 or less.
[0082] The weight ratio of the amount of (a) polydatin / (c) vitamin B3 compound may be 0.01 to 0.5, preferably 0.05 to 0.3, and more preferably 0.1 to 0.2.
[0083] The weight ratio of the amount of (c) vitamin B3 compound / (b) caffeoylquinic acid compound may be 1 or more, preferably 1.5 or more, and more preferably 2 or more.
[0084] The weight ratio of the amount of (c) vitamin B3 compound / (b) caffeoylquinic acid compound may be 8 or less, preferably 4 or less, and more preferably 3 or less.
[0085] The weight ratio of the amount of (c) vitamin B3 compound / (b) caffeoylquinic acid compound may be 1 to 8, preferably 1.5 to 4, and more preferably 2 to 3.
[0086] [water]
[0087] The composition according to the present invention comprises (d) water.
[0088] The amount of (d) water in the composition according to the present invention may be 50% by weight or more, preferably 60% by weight or more, and more preferably 70% by weight or more, relative to the total weight of the composition.
[0089] On the other hand, the amount of (d) water in the composition according to the present invention may be 95 wt % or less, preferably 90 wt % or less, and more preferably 85 wt % or less, relative to the total weight of the composition, provided that the amount of (d) water is not 0.
[0090] The amount of (d) water in the composition according to the invention may range from 50 to 95% by weight, preferably from 60 to 90% by weight, more preferably from 70 to 85% by weight, relative to the total weight of the composition.
[0091] [Solubilizer]
[0092] The composition according to the invention may also comprise at least one solubilizer. If two or more solubilizers are used, they may be identical or different.
[0093] The solubilizing agent can further dissolve (a) polydatin in (d) water.
[0094] One or more solubilizers may be hydrotropes, but a solubilizer need not be a hydrotrope. Hydrotropes (hydrotropes or hydrotropic agents) are a diverse class of water-soluble compounds characterized by an amphiphilic molecular structure and the ability to significantly increase the solubility of poorly soluble organic molecules in water.
[0095] Many hydrotropes have an aromatic structure containing an ionic portion, while a portion of the structure is a linear alkyl chain. Although hydrotropes are clearly similar to surfactants and have the ability to reduce surface tension, their small hydrophobic units and relatively short alkyl chains distinguish them as a separate class of amphiphiles. Therefore, they are not hydrophobic enough to produce well-organized self-associated structures, such as micelles, even at high concentrations.
[0096] Common hydrotropic molecules include: sodium 1,3-benzenedisulfonate, sodium benzoate, sodium 4-picolinate, sodium salicylate, sodium benzenesulfonate, caffeine, sodium p-toluenesulfonate, sodium butylmonoglycolsulfate, 4-aminobenzoic acid HCl, sodium cumenesulfonate, 2-methacryloyloxyethyl phosphorylcholine, resorcinol, butyl urea, pyrogallol, N-picolylmethylacetamide 3.5, procaine HCl, proline HCl, pyridine, 3-picolylmethylamine, sodium ibuprofen, sodium xylenesulfonate, ethyl carbamate, pyridoxal hydrochloride, sodium benzoate, 2-pyrrolidone, ethyl urea, N,N-dimethylacetamide, N-methylacetamide, and isoniazid. Hydrotropes can be found in Lee J. et al., "Hydrotropic Solubilization of Paclitaxel: Analysis of Chemical Structures for Hydrotropic Property", Pharmaceutical Research, Vol. 20, No. 7, 2003 and Lee S. et al., "Hydrotropic Polymers: Synthesis and Characterization of Polymers Containing Picolylnicotinamide Moieties", Macromolecules, 36, 2248-2255, 2003. Preferred hydrotropes may include caffeine, sodium PCA, sodium salicylate, urea and dihydroxyethyl urea.
[0097] The amount of the solubilizer in the composition according to the present invention may be 0.01 wt % or more, preferably 0.05 wt % or more, and more preferably 0.1 wt % or more, relative to the total weight of the composition.
[0098] On the other hand, the amount of solubilizer in the composition according to the present invention may be 4 wt % or less, preferably 3 wt % or less, and more preferably 2 wt % or less relative to the total weight of the composition, provided that the amount of solubilizer is not 0.
[0099] The amount of solubilizer in the composition according to the invention may range from 0.01% to 4% by weight, preferably from 0.05% to 3% by weight, more preferably from 0.1% to 2% by weight relative to the total weight of the composition.
[0100] [Oil]
[0101] The composition according to the invention may also comprise at least one oil. If two or more oils are used, they may be identical or different.
[0102] "Oil" herein means a fatty compound or substance in the form of a liquid or paste (not solid) at room temperature (25°C) under atmospheric pressure (760 mmHg). As the oil, those generally used in cosmetics can be used alone or in combination thereof. These oils may be volatile or nonvolatile.
[0103] The oil may be a non-polar oil such as hydrocarbon oil, silicone oil, etc.; a polar oil such as vegetable oil or animal oil, and ester oil or ether oil; or a mixture thereof.
[0104] The oil may be chosen from oils of vegetable or animal origin, synthetic oils, silicone oils, hydrocarbon oils and fatty alcohols.
[0105] As examples of vegetable oils, mention may be made of, for example, linseed oil, camellia oil, macadamia oil, corn oil, mink oil, olive oil, avocado oil, tea oil, castor oil, safflower oil, jojoba oil, sunflower oil, almond oil, rapeseed oil, sesame oil, soybean oil, peanut oil, and mixtures thereof.
[0106] As examples of animal oils, mention may be made of, for example, squalene and squalane.
[0107] As examples of synthetic oils, mention may be made of alkane oils such as isododecane and isohexadecane, ester oils, ether oils and artificial triglycerides.
[0108] The ester oil is preferably a saturated or unsaturated, linear or branched C1-C 26 Aliphatic monobasic or polybasic acids and saturated or unsaturated, straight-chain or branched C1-C 26 Liquid esters of aliphatic monohydric or polyhydric alcohols, the total number of carbon atoms in the ester being greater than or equal to 10.
[0109] Preferably, for esters of monohydric alcohols, at least one of the alcohol and the acid from which the esters of the invention are derived is branched.
[0110] Among the monoesters of monoacids and monoalcohols, mention may be made of ethyl palmitate, ethylhexyl palmitate, isopropyl palmitate, dicaprylyl carbonate, alkyl myristates, for example isopropyl myristate or ethyl myristate, isocetyl stearate, 2-ethylhexyl isononanoate, isononyl isononanoate, isodecyl neopentanoate and isostearyl neopentanoate.
[0111] C4-C can also be used 22 Dicarboxylic or tricarboxylic acids with C1-C 22 Esters of alcohols, and mono-, di- or tri-carboxylic acids with non-sugar C4-C 26 Esters of dihydric alcohols, trihydric alcohols, tetrahydric alcohols or pentahydric alcohols.
[0112] Mention may especially be made of: diethyl sebacate; isopropyl lauroyl sarcosinate; diisopropyl sebacate; bis(2-ethylhexyl) sebacate; diisopropyl adipate; di-n-propyl adipate; dioctyl adipate; bis(2-ethylhexyl) adipate; diisostearyl adipate; bis(2-ethylhexyl) maleate; triisopropyl citrate; triisocetyl citrate; triisostearyl citrate; glyceryl trilactate; tricaprylin; tri(octyldodecyl) citrate; trioleyl citrate; neopentyl glycol diheptanoate; diethylene glycol diisononanoate.
[0113] As ester oil, C6-C 30 And preferably C 12 -C 22 Sugar esters and diesters of fatty acids. Recall that the term "sugar" denotes an oxygen-carrying hydrocarbon-based compound containing several alcohol functions, with or without aldehyde or ketone functions, and which contains at least 4 carbon atoms. These sugars may be monosaccharides, oligosaccharides or polysaccharides.
[0114] Examples of suitable sugars that may be mentioned include sucrose (saccharose), glucose, galactose, ribose, fucose, maltose, fructose, mannose, arabinose, xylose and lactose, and derivatives thereof, in particular alkyl derivatives, such as methyl derivatives, for example methyl glucose.
[0115] The sugar esters of fatty acids may be selected in particular from the sugars described above and straight-chain or branched, saturated or unsaturated C6-C 30 And preferably C 12 -C 22 Esters or mixtures of esters of fatty acids. If the compounds are unsaturated, they may have one to three conjugated or nonconjugated carbon-carbon double bonds.
[0116] The esters according to this variant may also be chosen from monoesters, diesters, triesters, tetraesters and polyesters, and mixtures thereof.
[0117] These esters may be, for example, oleate, laurate, palmitate, myristate, behenate, cocoate, stearate, linoleate, linolenate, caprate and arachidonate, or mixtures thereof, such as, in particular, oleopalmitate, oleostearate and palmitostearate mixed esters, and pentaerythritol tetra(ethylhexanoate).
[0118] More particularly, monoesters and diesters are used, and especially sucrose, glucose or methylglucose mono- or dioleates, stearates, behenyl esters, Acid esters, palmitic acid esters, linoleic acid esters, linolenic acid esters and stearic acid esters.
[0119] An example that may be mentioned is the product sold by the company Amerchol under the name A product sold by DO which is methyl glucose dioleate.
[0120] As examples of preferred ester oils, mention may be made of, for example, diisopropyl adipate, dioctyl adipate, 2-ethylhexyl hexanoate, ethyl laurate, cetyl octanoate, octyldodecyl octanoate, isodecyl neopentanoate, myristyl propionate, 2-ethylhexyl 2-ethylhexanoate, 2-ethylhexyl octanoate, 2-ethylhexyl octanoate / caprate, methyl palmitate, ethyl palmitate, isopropyl palmitate, dicaprylyl carbonate, isopropyl lauroyl sarcosinate, isononyl isononanoate, ethylhexyl palmitate, isohexyl laurate, hexyl laurate, isocetyl stearate, isopropyl isostearate, isopropyl myristate, isodecyl oleate, glyceryl tri(2-ethylhexanoate), pentaerythritol tetra(2-ethylhexanoate), 2-ethylhexyl succinate, diethyl sebacate, and mixtures thereof.
[0121] As examples of artificial triglycerides, there may be mentioned, for example, capryl caprylylglyceride, trimyristin, tripalmitin, trilinolenic acid, trilaurin, tricaprin, tricaprylin, tri(caprylic acid / caprylic acid)glyceride and tri(capric acid / caprylic acid / linolenic acid)glyceride.
[0122] As examples of silicone oils, there may be mentioned, for example, linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane and the like; cyclic organopolysiloxanes such as cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane and the like; and mixtures thereof.
[0123] Preferably, the silicone oil is chosen from liquid polydialkylsiloxanes, especially liquid polydimethylsiloxane (PDMS), and liquid polyorganosiloxanes comprising at least one aromatic group.
[0124] These silicone oils may also be organomodified.The organomodified silicones that can be used according to the invention are silicone oils as defined above and that contain in their structure one or more organofunctional groups linked via hydrocarbon-based groups.
[0125] Organopolysiloxanes are defined in more detail in Walter Noll, Chemistry and Technology of Silicones (1968), Academic Press. They may be volatile or nonvolatile.
[0126] When the silicones are volatile, they are more particularly chosen from those having a boiling point between 60° C. and 260° C., and even more particularly from:
[0127] (i) Cyclic polydialkylsiloxanes containing 3 to 7 and preferably 4 to 5 silicon atoms. These are, for example, those sold in particular by Union Carbide under the name Volatile 7207 or by Rhodia under the name Octamethylcyclotetrasiloxane sold as 70045 V2; marketed by Union Carbide under the name Volatile 7158, by Rhodia under the name decamethylcyclopentasiloxane sold under the name Silsofil 70045V5 by Momentive Performance Materials; and dodecamethylcyclopentasiloxane sold under the name Silsofil 1217 by Momentive Performance Materials; and mixtures thereof. Mention may also be made, for example, of cyclic copolymers of the dimethylsiloxane / methylalkylsiloxane type, such as Silicone sold by the company Union Carbide. FZ 3109, which has the following formula:
[0128] Where D″:
[0129] Mention may also be made of mixtures of cyclic polydialkylsiloxanes with organosilicon compounds, for example a mixture of octamethylcyclotetrasiloxane and tetrakis(trimethylsilyl)pentaerythritol (50 / 50) and a mixture of octamethylcyclotetrasiloxane and oxy-1,1′-bis(2,2,2′,2′,3,3′-hexa(trimethylsiloxy))neopentane; and
[0130] (ii) contains 2 to 9 silicon atoms and has a carbon content of less than or equal to 5×10 -6 m 2Linear volatile polydialkylsiloxanes with a viscosity of 1.5 % to 2.5 % of the total weight of the silicone. An example is decamethyltetrasiloxane sold in particular by the company Toray Silicone under the name SH 200. Silicones belonging to this class are also described in the article Volatile Silicone Fluids for Cosmetics published by Todd & Byers in Cosmetics and Toiletries, Volume 91, January 1976, pages 27-32. The viscosity of the silicones is measured at 25° C. according to ASTM Standard 445, Appendix C.
[0131] It is also possible to use nonvolatile polydialkylsiloxanes. These nonvolatile silicones are more particularly chosen from polydialkylsiloxanes, among which mention may mainly be made of polydimethylsiloxanes containing trimethylsilyl end groups.
[0132] Among these polydialkylsiloxanes, mention may be made in a non-limiting manner of the following commercial products:
[0133] - 47 and 70047 series sold by Rhodia Oil or Oil, for example, oil 70047V500000;
[0134] -Sold by Rhodia Series of oils;
[0135] - Oils of the 200 series from Dow Corning, e.g. with a viscosity of 60,000 mm 2 / s DC 200; and
[0136] -From General Electric Oils and certain oils from General Electric's SF series (SF 96, SF 18).
[0137] Mention may also be made of the polydimethylsiloxanes containing dimethylsilanol end groups known under the name dimethiconol (CTFA), for example the oils of the 48 series from the company Rhodia.
[0138] Among the silicones containing aryl groups, mention may be made of the polydiarylsiloxanes, especially the polydiphenylsiloxanes and the polyalkylarylsiloxanes, such as phenyl silicone oils.
[0139] The phenyl silicone oil may be selected from the phenyl silicones of the following formula:
[0140]
[0141] in:
[0142] R1 to R 10are independently saturated or unsaturated, linear, cyclic or branched C1-C 30 A hydrocarbon group, preferably based on C1-C 12 a hydrocarbon group, and more preferably a C1-C6 hydrocarbon-based group, in particular a methyl, ethyl, propyl or butyl group, and m, n, p and q are independently of one another an integer from 0 to 900 (inclusive), preferably from 0 to 500 (inclusive), and more preferably from 0 to 100 (inclusive),
[0143] The condition is that the sum of n+m+q is not zero.
[0144] Examples which may be mentioned include the products sold under the following names:
[0145] - From the 70641 series of Rhodia Oil;
[0146] -From Rhodia Oils of the 70633 and 763 series;
[0147] - oil from Dow Corning Dow Corning 556 Cosmetic Grade Fluid;
[0148] - Silicones from the PK series from Bayer, for example the product PK20;
[0149] - Certain oils from General Electric's SF series, such as SF 1023, SF 1154, SF 1250 and SF1265.
[0150] As phenyl silicone oil, phenyl trimethicone (in the above formula, R1 to R 10 is methyl; p, q and n=0; m=1) is preferred.
[0151] The organomodified liquid silicones may contain especially polyethyleneoxy and / or polypropyleneoxy groups. Mention may thus be made of silicone KF-6017 proposed by Shin-Etsu, and oils from the company Union Carbide. L722 and L77.
[0152] The hydrocarbon oil may be selected from:
[0153] - straight-chain or branched, optionally cyclic C6-C 16 Lower alkanes. Examples that may be mentioned include hexane, undecane, dodecane, tridecane, and isoparaffins such as isohexadecane, isododecane and isodecane; and
[0154] - straight-chain or branched hydrocarbons containing more than 16 carbon atoms, such as liquid paraffin, liquid petroleum jelly, polydecene and hydrogenated polyisobutylene (e.g. ), and squalane.
[0155] As preferred examples of hydrocarbon oils, there may be mentioned, for example, linear or branched hydrocarbons such as isohexadecane, isododecane, squalane, mineral oils (e.g., liquid paraffin), paraffin, vaseline or petrolatum, naphthalene and the like; hydrogenated polyisobutene, isoeicosan, and decene / butene copolymers; and mixtures thereof.
[0156] The term "fatty" in fatty alcohol means that it contains a relatively large number of carbon atoms. Therefore, alcohols with 4 or more, preferably 6 or more, and more preferably 12 or more carbon atoms are included in the scope of fatty alcohol. Fatty alcohol can be saturated or unsaturated. Fatty alcohol can be straight chain or branched.
[0157] The fatty alcohol may have the structure R-OH, wherein R is selected from saturated and unsaturated, linear and branched groups containing 4 to 40 carbon atoms, preferably 6 to 30 carbon atoms, and more preferably 12 to 20 carbon atoms. In at least one embodiment, R may be selected from C 12 -C 20 Alkyl and C 12 -C 20 R may or may not be substituted with at least one hydroxyl group.
[0158] As examples of fatty alcohols, mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, Alcohol, undecyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, oleyl alcohol, linoleyl alcohol, palmitoleyl alcohol, arachidonic acid, erucic acid, and mixtures thereof.
[0159] Preferably the fatty alcohol is a saturated fatty alcohol.
[0160] Therefore, the fatty alcohol can be selected from linear or branched, saturated or unsaturated C6-C 30 Alcohol, preferably a linear or branched saturated C6-C 30 Alcohol, and more preferably a linear or branched saturated C 12 -C 20 alcohol.
[0161] The term "saturated fatty alcohol" herein refers to an alcohol having a long aliphatic saturated carbon chain. Preferably, the saturated fatty alcohol is selected from any linear or branched saturated C6-C 30 Fatty alcohol. In straight or branched chain saturated C6-C 30 Among fatty alcohols, linear or branched saturated C 12 -C 20 Fatty alcohols. Any linear or branched saturated C 16 -C 20Even more preferably, branched C 16 -C 20 Fatty alcohol.
[0162] As examples of saturated fatty alcohols, mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, and mixtures thereof. In one embodiment, cetyl alcohol, stearyl alcohol, octyldodecanol, hexyldecanol, or mixtures thereof (e.g., cetearyl alcohol) and behenyl alcohol may be used. Alcohols are saturated fatty alcohols.
[0163] According to at least one embodiment, the fatty alcohol used in the composition according to the invention is preferably chosen from cetyl alcohol, octyldodecanol, hexyldecanol, and mixtures thereof.
[0164] It is also preferred that the oil is selected from oils having a molecular weight below 600 g / mol.
[0165] Preferably, the oil has a low molecular weight, for example below 600 g / mol, selected from oils having one or more short hydrocarbon chains (C1-C 12 ) ester oils (e.g., isopropyl lauroyl sarcosinate, isopropyl myristate, isopropyl palmitate, isononyl isononanoate and ethylhexyl palmitate), silicone oils (e.g., volatile silicones such as cyclohexasiloxane), hydrocarbon oils (e.g., isododecane, isohexadecane and squalane), branched and / or unsaturated fatty alcohols (C 12 -C 30 ) type oils, such as octyldodecanol and oleyl alcohol, and ether oils, such as dicaprylyl ether.
[0166] Preferably the oil is selected from polar oils, and more preferably from ester oils.
[0167] The amount of oil in the composition according to the invention may be 0.01% by weight or more, preferably 0.05% by weight or more and more preferably 0.1% by weight or more relative to the total weight of the composition.
[0168] The amount of oil in the composition according to the invention may be 10 wt% or less, preferably 5 wt% or less and more preferably 1 wt% or less relative to the total weight of the composition, provided that the amount of oil is not zero.
[0169] The amount of oil in the composition according to the invention may range from 0.01% to 10% by weight, preferably from 0.05% to 5% by weight and more preferably from 0.1% to 1% by weight relative to the total weight of the composition.
[0170] [Emulsifier]
[0171] The composition according to the invention may also comprise at least one emulsifier. If two or more emulsifiers are used, they may be identical or different.
[0172] The emulsifier may be a surfactant. The surfactant may be selected from cationic, anionic, amphoteric and nonionic surfactants. It may be preferred that the composition according to the present invention comprises at least one anionic surfactant and at least one nonionic surfactant.
[0173] The anionic surfactant may preferably be selected from amino acid type surfactants.
[0174] Non-limiting examples of amino acid type surfactants include potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium decanoyl methyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium methyl myristoyl taurate, sodium methyl oleoyl taurate, sodium methyl palmitoyl taurate, sodium methyl stearoyl taurate, dipotassium capryloyl glutamate, dipotassium undecylenoyl glutamate, disodium capryloyl glutamate, disodium cocoyl glutamate, disodium lauroyl glutamate, disodium stearoyl glutamate, disodium undecylenoyl glutamate, potassium capryloyl glutamate, potassium cocoyl glutamate, potassium lauroyl glutamate, potassium myristoyl glutamate, potassium stearoyl glutamate, potassium undecylenoyl glutamate, sodium capryloyl glutamate, disodium Sodium glutamate, sodium lauroyl glutamate, sodium myristoyl glutamate, sodium oliveoyl glutamate, sodium palmitoyl glutamate, sodium stearoyl glutamate, sodium undecylenyl glutamate, cocoyl methyl beta-alanine, lauroyl beta-alanine, lauroyl methyl beta-alanine, myristoyl beta-alanine, potassium lauroyl methyl beta-alanine, sodium cocoyl alanine, sodium cocoyl methyl beta-alanine, and sodium myristoyl methyl beta-alanine, palmitoyl glycine, sodium lauroyl glycinate, sodium cocoyl glycinate, sodium myristoyl glycinate, potassium lauroyl glycinate, potassium cocoyl glycinate, potassium lauroyl sarcosinate, potassium cocoyl sarcosinate, sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, and sodium palmitoyl sarcosinate, and mixtures thereof.
[0175] Mention is also made of potassium lauroyl sarcosinate, potassium cocoyl sarcosinate, sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, sodium lauroyl aspartate, sodium myristoyl aspartate, sodium cocoyl aspartate, sodium caproyl aspartate, disodium lauroyl aspartate, disodium myristoyl aspartate, disodium cocoyl aspartate, disodium caproyl aspartate, potassium lauroyl aspartate, potassium myristoyl aspartate, potassium cocoyl aspartate, potassium caproyl aspartate, dipotassium lauroyl aspartate, dipotassium myristoyl aspartate, dipotassium cocoyl aspartate, dipotassium caproyl aspartate, and mixtures thereof.
[0176] The amount of the amino acid-type surfactant in the composition according to the present invention may be 0.001 wt % or more, preferably 0.005 wt % or more, and more preferably 0.01 wt % or more, relative to the total weight of the composition.
[0177] On the other hand, the amount of the amino acid surfactant in the composition according to the present invention may be 1 wt % or less, preferably 0.5 wt % or less, and more preferably 0.1 wt % or less, relative to the total weight of the composition, provided that the amount of the amino acid surfactant is not 0.
[0178] The amount of amino acid surfactant in the composition according to the present invention may range from 0.001 to 1 wt%, preferably 0.005 to 0.5 wt%, more preferably 0.01 to 0.1 wt%, relative to the total weight of the composition.
[0179] It may be preferred that the composition according to the invention comprises at least one nonionic surfactant, more preferably at least one polyglycerol fatty acid ester, and even more preferably a combination of a first and a second polyglycerol fatty acid ester.
[0180] (First polyglycerol fatty acid ester)
[0181] The composition according to the present invention may include at least one first polyglycerol fatty acid ester having an HLB value of 12.0 or higher, preferably 12.5 or higher, and more preferably 13.0 or higher. A single type of first polyglycerol fatty acid ester may be used, but two or more different types of first polyglycerol fatty acid esters may be used in combination.
[0182] The first polyglycerol fatty acid ester may function as a surfactant, particularly a nonionic surfactant.
[0183] The first polyglycerol fatty acid may have an HLB value of 12.0 to 17.0, preferably 12.5 to 16.0, and more preferably 13.5 to 15.0.
[0184] The term HLB ("hydrophile-lipophile balance") is well known to those skilled in the art and reflects the ratio between the hydrophilic and lipophilic parts of a molecule.
[0185] If two or more first polyglycerol fatty acid esters are used, the HLB value is determined by a weighted average of the HLB values of all first polyglycerol fatty acid esters.
[0186] The first polyglycerol fatty acid ester may be selected from mono-, di-, tri- and more polyesters of saturated or unsaturated fatty acids.
[0187] It is preferred that the first polyglycerol fatty acid ester contains 2 to 4 glycerol units, preferably 3 or 4 glycerol units, and more preferably 4 glycerol units.
[0188] The fatty acid or fatty acid moiety of the fatty acid portion of the first polyglycerol fatty acid ester may contain 12 or less carbon atoms, preferably 11 or less carbon atoms, more preferably 10 or less carbon atoms. The fatty acid or fatty acid moiety of the fatty acid portion of the first polyglycerol fatty acid ester may contain 4 or more carbon atoms, preferably 6 or more carbon atoms, and more preferably 8 or more carbon atoms. The fatty acid or fatty acid moiety of the fatty acid portion of the first polyglycerol fatty acid ester may have 4 to 12, preferably 6 to 11 carbon atoms, and more preferably 8 to 10 carbon atoms.
[0189] The fatty acid of the fatty acid portion of the first polyglycerol fatty acid ester may be saturated or unsaturated, and may be selected from caprylic acid, capric acid, and lauric acid.
[0190] The first polyglycerol fatty acid ester can be selected from PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), PG5 myristate (HLB: 15.4), PG5 stearate (HLB: 15), PG6 caprylate (HLB: 14.6), PG6 caprate (HLB: 13.1), PG6 laurate (HLB: 14.1), PG10 laurate (HLB: 15.2), PG10 myristate (HLB: 14.9), PG10 stearate (HLB: 14.1), PG10 isostearate (HLB: 13.7), PG10 oleate (HLB: 13.0), PG10 cocoate (HLB: 16), and mixtures thereof.
[0191] It may be preferred that the first polyglycerol fatty acid ester is selected from PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), and a mixture thereof.
[0192] The amount of the first polyglycerol fatty acid ester in the composition according to the present invention may be 0.01 wt % or more, preferably 0.05 wt % or more, and more preferably 0.1 wt % or more, relative to the total weight of the composition.
[0193] On the other hand, the amount of the first polyglycerol fatty acid ester in the composition according to the present invention can be 15 wt % or less, preferably 10 wt % or less, and more preferably 5 wt % or less, relative to the total weight of the composition, provided that the amount of the first polyglycerol fatty acid ester is not 0.
[0194] The amount of the first polyglycerol fatty acid ester in the composition according to the present invention may range from 0.01 to 15 wt %, preferably from 0.05 to 10 wt %, and more preferably from 0.1 to 5 wt % relative to the total weight of the composition.
[0195] (Second polyglycerol fatty acid ester)
[0196] The composition according to the present invention may include at least one second polyglycerol fatty acid ester having an HLB value of 10.0 or less, preferably 9.5 or less, and more preferably 9.0 or less. A single type of second polyglycerol fatty acid ester may be used, but two or more different types of second polyglycerol fatty acid esters may be used in combination.
[0197] The second polyglycerol fatty acid ester may act as a surfactant, particularly a nonionic surfactant.
[0198] The second polyglycerol fatty acid may have an HLB value of 5.0 to 10.0, preferably 6.0 to 9.5, and more preferably 7.0 to 9.0.
[0199] If two or more second polyglycerol fatty acid esters are used, the HLB value is determined by a weighted average of the HLB values of all the second polyglycerol fatty acid esters.
[0200] The second polyglycerol fatty acid ester may be selected from mono-, di-, tri- and higher polyesters of saturated or unsaturated fatty acids.
[0201] It is preferred that the second polyglycerol fatty acid ester contains 2 to 4 glycerol units, preferably 2 or 3 glycerol units, and more preferably 2 glycerol units.
[0202] The fatty acid or fatty acid moiety of the fatty acid portion of the second polyglycerol fatty acid ester may contain 14 or more carbon atoms, preferably 16 or more carbon atoms, and more preferably 18 or more carbon atoms. The fatty acid or fatty acid moiety of the fatty acid portion of the second polyglycerol fatty acid ester may contain 30 or less carbon atoms, preferably 24 or less carbon atoms, and more preferably 20 or less carbon atoms. The fatty acid or fatty acid moiety of the fatty acid portion of the second polyglycerol fatty acid ester may have 14 to 30, preferably 16 to 24, and more preferably 18 to 20 carbon atoms.
[0203] The fatty acid of the fatty acid portion of the second polyglycerol fatty acid ester may be saturated or unsaturated, and may be selected from myristic acid, stearic acid, isostearic acid, and oleic acid.
[0204] The second polyglycerol fatty acid ester may be selected from PG2 stearate (HLB: 5.0), PG2 distearate (HLB: 4), PG2 isostearate (HLB: 8), PG2 diisostearate (HLB: 3.2), PG2 triisostearate (HLB: 3), PG2 sesquiisostearate (HLB: about 4), PG2 oleate (HLB: 8), PG2 sesquioleate (HLB: 5.3), PG3 distearate (HLB: 5), PG3 diisostearate (HLB: 5), PG3 dicocoate (HLB: 7), PG5 hexastearate (HLB: 4.0), PG5 trioleate (HLB: 7.0), PG10 pentaoleate (HLB: 6 .4), PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), PG6 distearate (HLB: 8), PG10 distearate (HLB: about 9), PG10 tristearate (HLB: 8), PGl0 diisostearate (HLB: 10), PG10 triisostearate (HLB: 8), PGl0 tricocoate (HLB: 9), and mixtures thereof.
[0205] The second polyglycerol fatty acid may preferably be selected from PG2 stearate (HLB: 5.0), PG2 distearate (HLB: 4), PG2 isostearate (HLB: 8), PG2 diisostearate (HLB: 3.2), PG2 triisostearate (HLB: 3), PG2 sesquiisostearate (HLB: about 4), PG2 oleate (HLB: 8), PG2 sesquioleate (HLB: 5.3), PG3 distearate (HLB: 5), PG PG3 diisostearate (HLB: 5), PG3 dicocoate (HLB: 7), PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), and mixtures thereof.
[0206] The amount of the second polyglycerol fatty acid ester in the composition according to the present invention may be 0.01 wt % or more, preferably 0.05 wt % or more, and more preferably 0.1 wt % or more, relative to the total weight of the composition.
[0207] On the other hand, the amount of the second polyglycerol fatty acid ester in the composition according to the present invention may be 10 wt % or less, preferably 5 wt % or less, and more preferably 1 wt % or less, relative to the total weight of the composition, provided that the amount of the second polyglycerol fatty acid ester is not 0.
[0208] The amount of the second polyglycerol fatty acid ester in the composition according to the present invention may be in the range of 0.01 wt % to 10 wt %, preferably 0.05 wt % to 5 wt %, more preferably 0.1 wt % to 1 wt % relative to the total weight of the composition.
[0209] (About weight ratio of polyglycerol fatty acid ester)
[0210] According to the present invention, the weight ratio of (the total amount of the first polyglycerol fatty acid ester and the second polyglycerol fatty acid ester) / the amount of oil may be 4.0 or less, preferably 3.0 or less, and more preferably 2.0 or less.
[0211] Typically, the weight ratio of the amount of glycerol fatty acid ester / oil is much higher, for example 6.0.
[0212] Therefore, the composition according to the present invention can reduce or limit the total amount of polyglycerol fatty acid esters.
[0213] Since the present invention can reduce the total amount of polyglycerol fatty acid ester, the composition according to the present invention can provide a non-sticky touch or can provide a further reduced sticky touch.
[0214] It may be preferred that the weight ratio of (the total amount of the first polyglycerol fatty acid ester and the second polyglycerol fatty acid ester) / the amount of oil is higher than 0.5, preferably higher than 1.0, and more preferably higher than 1.5.
[0215] On the other hand, according to the present invention, the weight ratio of the amount of the first polyglycerol fatty acid ester / the second polyglycerol fatty acid ester may be 1 or more, preferably 1.5 or more, and more preferably 2 or more; may be 5 or less, preferably 4 or less, and more preferably 3 or less; and may be 1 to 5, preferably 1.5 to 4, and more preferably 2 to 3.
[0216] (Average HLB of polyglycerol fatty acid esters)
[0217] The average HLB value of the first polyglycerol fatty acid ester and the second polyglycerol fatty acid ester may be calculated as a weighted average of all the first and second polyglycerol fatty acid esters.
[0218] The average HLB of the first polyglycerol fatty acid ester and the second polyglycerol fatty acid ester in the composition according to the present invention may be 11.0 or higher, preferably 11.5 or higher, and more preferably 12.0 or higher.
[0219] The average HLB of the first polyglycerol fatty acid ester and the second polyglycerol fatty acid ester in the composition according to the present invention may be 14.0 or less, preferably 13.5 or less, and more preferably 13.0 or less.
[0220] Therefore, in one embodiment of the present invention, the average HLB of the first polyglycerol fatty acid ester and the second polyglycerol fatty acid ester in the composition according to the present invention may be in the range of 11.0 to 14.0, preferably 11.5 to 13.5, and more preferably 12.0 to 13.0.
[0221] [Polyol]
[0222] The composition according to the present invention may further comprise at least one polyol.A single type of polyol may be used, but two or more different types of polyols may be used in combination.
[0223] The term "polyol" herein means an alcohol having two or more hydroxyl groups, and does not include sugars or derivatives thereof. Derivatives of sugars include sugar alcohols obtained by reducing one or more carbonyl groups of sugars, and sugars or sugar alcohols in which one or more hydrogen atoms in one or more hydroxyl groups thereof are replaced by at least one substituent such as an alkyl group, a hydroxyalkyl group, an alkoxy group, an acyl group, or a carbonyl group.
[0224] The polyol can be C2-C 12 A polyol, preferably a C2-C9 polyol, comprising at least 2 hydroxyl groups and preferably 2 to 5 hydroxyl groups.
[0225] The polyol may be a natural polyol or a synthetic polyol. The polyol may have a linear, branched or cyclic molecular structure.
[0226] The polyol may be selected from glycerol and its derivatives, and diols and their derivatives. The polyol may be selected from glycerol, diglycerol, polyglycerol, ethylene glycol, diethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol, 1,3-propanediol, 1,5-pentanediol, caprylyl glycol, polyethylene glycol (5 to 50 ethylene oxide groups) and sugars such as sorbitol.
[0227] The amount of polyol in the composition according to the invention may be 0.01 wt % or more, preferably 0.05 wt % or more, and more preferably 0.1 wt % or more, relative to the total weight of the composition.
[0228] On the other hand, the amount of polyol in the composition according to the present invention may be 25 wt % or less, preferably 20 wt % or less, and more preferably 15 wt % or less relative to the total weight of the composition, provided that the amount of polyol is not zero.
[0229] Thus, the polyol may be present in the composition according to the invention in an amount ranging from 0.01% to 25% by weight and preferably from 0.05% to 20% by weight, for example from 0.1% to 15% by weight relative to the total weight of the composition.
[0230] [Other ingredients]
[0231] The composition according to the invention may also comprise one or more monohydric alcohols which are in liquid form at room temperature (25° C.), such as, for example, linear or branched monohydric alcohols containing 1 to 6 carbon atoms, such as ethanol, propanol, butanol, isopropanol, isobutanol, pentanol and hexanol.
[0232] The amount of monohydric alcohol in the composition according to the present invention may be 0.01 wt % or more, preferably 0.1 wt % or more, and more preferably 1 wt % or more, relative to the total weight of the composition.
[0233] On the other hand, the amount of monohydric alcohol in the composition according to the present invention may be 15 wt % or less, preferably 10 wt % or less, and more preferably 5 wt % or less, relative to the total weight of the composition.
[0234] Thus, the amount of monohydric alcohol in the composition according to the invention may range from 0.01% to 15% by weight, preferably from 0.1% to 10% by weight and more preferably from 1% to 5% by weight relative to the total weight of the composition.
[0235] In addition to the ingredients described above, the compositions according to the invention may also include various adjuvants commonly used in cosmetic and dermatological compositions, such as thickeners; anionic, nonionic, cationic and amphoteric or zwitterionic polymers; additional antioxidants; colorants; chelating agents; sequestering agents; fragrances; dispersants; conditioning agents; film formers; preservatives; preservative aids, and mixtures thereof.
[0236] The composition according to the invention may further comprise baicalin. If the composition according to the invention comprises baicalin, it may be preferred that the amount of baicalin is limited to 0.5 wt% or less relative to the total weight of the composition. The composition according to the invention may not comprise baicalin.
[0237] In one embodiment, the composition according to the invention may not contain any UV filters, since it is stable with respect to light. The term "free" here means that the composition according to the invention may contain a limited amount of at least one UV filter. However, it is preferred to limit the amount of UV filters so that it is less than 1% by weight, more preferably less than 0.1% by weight, and even more preferably less than 0.01% by weight relative to the total weight of the composition. It may be most preferred that the composition according to the invention does not contain UV filters.
[0238] In another embodiment, the composition according to the present invention may not contain a nonionic surfactant based on polyoxyethylene. The term "free" means that the composition according to the present invention may contain a limited amount of a nonionic surfactant based on polyoxyethylene. However, it is preferred to limit the amount of the nonionic surfactant based on polyoxyethylene so that it is less than 1 weight %, more preferably less than 0.1 weight % and even more preferably less than 0.01 weight % relative to the total weight of the composition. It is most preferred that the composition according to the present invention does not contain a nonionic surfactant based on polyoxyethylene.
[0239] (preparation)
[0240] The composition according to the present invention can be prepared by mixing the essential ingredients as described above and, if desired, the optional ingredients as described above.
[0241] (a) Polydatin can be obtained from plants. Therefore, for example, a plant extract containing (a) Polydatin can be used as (a) Polydatin. For example, a root extract of Polygonium Cuspidatum sold by Guilin Layn Natural Ingredients can be used as (a) Polydatin.
[0242] (b) Caffeoylquinic acid compounds can be obtained from plants. Therefore, for example, a plant extract containing (b) caffeoylquinic acid compounds can be used as (b) caffeoylquinic acid compounds. For example, Eucommia ulmoides leaf extract chlorogenic acid 98% sold by Guilin Laiyin Biotechnology Co., Ltd. can be used as (b) caffeoylquinic acid compounds.
[0243] Therefore, the composition according to the present invention can be prepared by mixing, for example, (a) polydatin and / or a first plant extract comprising (a) polydatin and (b) a caffeoylquinic acid compound and / or a second plant extract comprising (b) a caffeoylquinic acid compound, as well as the above-mentioned components (c) and (d) and the optional components as described above (if necessary).
[0244] The method and means of mixing the above essential ingredients and optional ingredients are not limited. Any conventional method and means may be used to mix the above essential ingredients and optional ingredients to prepare the composition according to the present invention.
[0245] The composition according to the present invention can be prepared without requiring a large amount of energy (e.g., required for a homogenizer). Therefore, the composition according to the present invention can be prepared by using a small amount of energy, such as gently stirring the ingredients of the composition. Therefore, the composition according to the present invention is environmentally friendly in view of its preparation route.
[0246] [form]
[0247] The composition according to the present invention is not limited. For example, the composition according to the present invention may be in the form of an aqueous solution.
[0248] If the composition according to the invention comprises at least one oil, it is preferred that the composition according to the invention is in the form of an O / W emulsion comprising an oil phase dispersed in a continuous aqueous phase. The dispersed oil phase may be oil droplets in the aqueous phase. In this case, it is preferred that the composition according to the invention comprises at least one emulsifier as described above.
[0249] The O / W constitution or structure consisting of an oil phase dispersed in an aqueous phase has an external aqueous phase, and therefore, if the composition according to the present invention has an O / W constitution or structure, it can provide a pleasant feeling during use due to the immediate freshness that the aqueous phase can provide.
[0250] The composition according to the invention may be in the form of a nanoemulsion or a microemulsion.
[0251] "Microemulsion" can be defined in two ways, i.e., in a broad sense and in a narrow sense. That is, there is a case ("microemulsion in the narrow sense"), in which microemulsion refers to a thermodynamically stable, isotropic single liquid phase containing a ternary system having three components: an oil component, an aqueous component, and a surfactant; and there is a second case ("microemulsion in the broad sense"), in which, among thermodynamically unstable typical emulsion systems, microemulsions additionally include those such emulsions that exhibit a transparent or translucent appearance due to their small particle size (Satoshi Tomomasa et al., Oil Chemistry, Vol. 37, No. 11 (1988), pp. 48-53). As used herein, "microemulsion" refers to a "microemulsion in the narrow sense", i.e., a thermodynamically stable, isotropic single liquid phase.
[0252] The microemulsion refers to any state of an O / W (oil-in-water) type microemulsion in which oil is solubilized by micelles, a W / O (water-in-oil) type microemulsion in which water is solubilized by reverse micelles, or a bicontinuous microemulsion in which the number of associations of surfactant molecules becomes infinite so that both the water phase and the oil phase have a continuous structure.
[0253] The microemulsion may have a dispersed phase having a particle size of 100 nm or less, preferably 50 nm or less, and more preferably 20 nm or less, as measured by laser granulometry.
[0254] "Nanoemulsion" means here an emulsion characterized by a dispersed phase with a size of less than 350 nm, stabilized by a crown of (b) and (c) nonionic surfactants that can optionally form a liquid crystal phase of lamellar type at the dispersed phase / continuous phase interface. In the absence of specific sunscreens, the transparency of the nanoemulsions comes from the small size of the dispersed phase, which is obtained by using mechanical energy.
[0255] Nanoemulsions can be distinguished from microemulsions by their structure. Specifically, microemulsions are thermodynamically stable dispersions formed by micelles formed, for example, by an emulsifier and filled with oil. In addition, microemulsions do not require a large amount of mechanical energy to prepare.
[0256] The nanoemulsion may have a dispersed phase having a particle size of 300 nm or less, preferably 200 nm or less, and more preferably 100 nm or less, as measured by laser granulometry.
[0257] If the composition according to the invention is in the form of an O / W emulsion, it is even more preferred that the particle size of the (a) oil is 35 nm or less, preferably 30 nm or less, and more preferably 25 nm or less. The particle size can be measured by dynamic light scattering. The particle size measurement can be carried out by, for example, an ELSZ-2000 series particle size analyzer sold by Otsuka Electronics Co., Ltd.
[0258] The particle size may be a volume average particle size or a number average particle size, preferably a volume average particle size.
[0259] The composition according to the invention may be transparent.
[0260] Transparency can be measured by measuring turbidity. For example, turbidity can be measured using a 2100Q (sold by the Hach company) with a circular cell (25 mm diameter and 60 mm height) and a tungsten lamp that emits visible light (between 400 and 800 nm, preferably 400 to 500 nm). The measurement can be performed on the undiluted composition. A blank can be measured with distilled water.
[0261] The composition according to the present invention has a turbidity of 150 NTU or less, preferably 130 NTU or less, and more preferably 110 NTU or less.
[0262] It may be more preferred that the composition according to the invention is in the form of a nano O / W emulsion or a micro O / W emulsion.
[0263] It may even be more preferred that the composition according to the invention is in the form of a nano O / W gel emulsion or a micro O / W gel emulsion. For example, the aqueous phase of the nano O / W gel emulsion or the micro O / W gel emulsion may comprise at least one thickener such as xanthan gum.
[0264] [Methods and Uses]
[0265] Preferably, the composition according to the invention is a cosmetic or dermatological composition, preferably a cosmetic composition, and more preferably a dermocosmetic composition.The composition according to the invention may be in the form of an emulsion, a cream, a serum, or the like.
[0266] The composition according to the invention can be used in a non-therapeutic method, such as a cosmetic method, for treating keratinous materials by application to keratinous materials such as the skin, in particular the face.
[0267] The invention therefore also relates to a cosmetic method for treating keratinous materials such as the skin, comprising the step of applying to the keratinous materials a composition according to the invention.
[0268] The present invention may also relate to the use of the composition according to the invention as a cosmetic product, such as a skin care product or in it. The skin care product may be an emulsion, a cream, a serum or the like.
[0269] In other words, the composition according to the present invention can be used as a cosmetic product as it is. Alternatively, the composition according to the present invention can be used as an element of a cosmetic product. For example, the composition according to the present invention can be added to any other element or combined with any other element to form a cosmetic product.
[0270] Another aspect of the present invention may relate to:
[0271] (b) at least one caffeoylquinic acid compound; and
[0272] (c) at least one vitamin B3 compound,
[0273] Use for stabilizing (a) polydatin in a composition comprising (d) water, in particular for photostability.
[0274] Another aspect of the present invention may also relate to:
[0275] (b) at least one caffeoylquinic acid compound; and
[0276] (c) at least one vitamin B3 compound,
[0277] Use of (a) polydatin as a stabilizer, in particular a stabilizer against light, in a composition comprising (d) water.
[0278] The explanations above for the composition according to the invention about components (a) to (d), and optional ingredients, can be applied to those for the uses and methods according to the invention. The explanations about the preparation and form of the composition according to the invention can also be applied to those of the compositions described in the above uses and methods. Example
[0279] The present invention will be described in more detail by way of examples, which, however, should not be construed as limiting the scope of the present invention.
[0280] [Examples 1-3 and Comparative Examples 1-5]
[0281] The following compositions in the form of microemulsions according to Examples 1 to 3 and Comparative Examples 1 to 5 shown in Table 1 were prepared by mixing the ingredients shown in Table 1 below. The numerical values of the amounts of the ingredients shown in Table 1 are all based on "weight %" as active raw materials.
[0282] Table 1
[0283]
[0284] [evaluate]
[0285] (Thermal stability)
[0286] Each of the compositions according to Examples 1 to 3 and Comparative Examples 1 to 5 was filled in a transparent glass bottle, and the glass bottle was stored at a temperature of 4° C. for 1 month. After 1 month, the appearance of the glass bottle was visually observed and evaluated according to the following criteria.
[0287] Good: No crystal particles were observed
[0288] Poor: Crystalline particles observed
[0289] The results are shown in Table 1 in the "Thermal Stability" row.
[0290] The compositions according to Examples 1 to 3 and Comparative Examples 1, 4 and 5 were stable for a long period of time even at cold temperatures so that no crystalline particles were formed.
[0291] The compositions according to Comparative Examples 2 and 3 were unstable so as to form crystal particles at a cold temperature. Therefore, it was found that using baicalin in an amount of 1.0 wt % or more was not preferable for preparing a thermally stable composition.
[0292] (Light stability)
[0293] Each of the compositions according to Examples 1 to 3 and Comparative Examples 1, 4 and 5 was added at 2 mg / cm 2 The amount of polydatin was spread on two glass plates. One of the two glass plates was placed under a xenon lamp, and the other was placed in the dark. They were left at a temperature of 25°C for 30 minutes. Subsequently, the two glass plates were immersed in 25g of methanol and stirred with a stirrer tip for 30 minutes to extract polydatin. The methanol solution was measured by HPLC (reverse phase) to quantify polydatin. The photostability of polydatin was calculated by the following equation:
[0294] Photostability (%) = (polydatin with Xe light (%)) / (polydatin without Xe light (%))
[0295] The results are shown in the "Photostability" row in Table 1. "NA" in Table 1 means not available.
[0296] The composition according to Examples 1-3 was more stable under light, such that 50% of polydatin was retained even after exposure to light.
[0297] The compositions according to Comparative Examples 1, 4 and 5 were less stable under light, so that their light stability was less than 50%.
Claims
1. A composition comprising: (a) Polydatin; (b) chlorogenic acid; (c) niacinamide; and (d) water, in The amount of (b) chlorogenic acid is 0.5 wt% or more relative to the total weight of the composition, and The amount of (c) niacinamide is 0.1 wt % to 15 wt % relative to the total weight of the composition.
2. The composition according to claim 1, wherein the (a) polydatin is obtained from a plant.
3. The composition according to claim 1, wherein the amount of the (a) polydatin in the composition is in the range of 0.01 wt% to 3 wt% relative to the total weight of the composition. The composition according to claim 1 , wherein the (b) chlorogenic acid is obtained from plants.
5. The composition according to claim 1, wherein the amount of the (b) chlorogenic acid in the composition is in the range of 0.5 wt% to 15 wt% relative to the total weight of the composition.
6. The composition according to claim 1, wherein the amount of the (c) niacinamide in the composition is in the range of 0.5 wt% to 10 wt% relative to the total weight of the composition. 7 . The composition according to claim 1 , wherein the weight ratio of the amount of (a) polydatin / the amount of (b) chlorogenic acid is 0.1 to 1. 8 . The composition according to claim 1 , wherein the weight ratio of the amount of (a) polydatin / the amount of (c) nicotinamide is 0.01 to 0.
5. 9 . The composition according to claim 1 , wherein the weight ratio of the amount of (c) niacinamide / the amount of (b) chlorogenic acid is 1 to 8.
10. The composition according to claim 1, wherein the composition is in the form of an O / W emulsion.
11. A non-therapeutic cosmetic method for treating keratinous materials, comprising the step of applying to said keratinous materials a composition according to any one of claims 1 to 10.
